Search Medical Condition
Please enter condition
Please choose location from dropdown

Liver Disorders Clinical Trials

A listing of Liver Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (154) clinical trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Study Evaluating the Safety and Efficacy of Obeticholic Acid (study medication) in Subjects with Nonalcoholic Steatohepatitis (NASH).

Phase

A Randomized, Double-Blind, Parallel-Group Dose-Ranging Study to Evaluate the Safety and Efficacy of NI-03 (Study Medication) compared to Placebo in Subjects with Chronic Pancreatitis.

Phase N/A

A study of an investigational treatment in patients with anal fissures. REF: x41

Phase

People with nonalcoholic steatohepatitis are asked to participate in a research study being conducted by North Shore University Hospital, Northwell Health

Phase N/A

To study the investigational drug, obeticholic acid (also known as OCA), and its effect on NASH and to find out how safe and effective OCA may be in delaying specific medical conditions or health related issues that can occur in patients with NASH and evidence of liver fibrosis. Patients will ...

Phase

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver.   ClinSearch is enrolling volunteers with a condition called liver fibrosis from NASH in a study testing the effectiveness and safety of an investigational medication.     Qualified participants may receive: - Study-related medication at no ...

Phase N/A

People with liver disorder are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

The primary objectives of this study are to evaluate the effect of Obeticholic Acid treatment compared to placebo on 1) histological improvement and 2) liver-related clinical outcomes in patients with non-cirrhotic nonalcoholic steatohepatitis (NASH) with liver fibrosis.

Phase N/A

Luminist’s diagnostic technology may aid in the diagnosis of steatohepatitis (SH) and/or fibrosis in patients with NAFLD who are at increased risk of having SH and/or fibrosis.

Phase N/A